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Summary
Possible mechanisms of graft-vs.-host (GVH) resistance have been studied using a panel of seven
class II major histocompatibility complex-specificT cell clones for elicitation and challenge. One
clone recognized I-AkAf, and expressed Vf8.3 together with J01.5 . The remaining six clones
were I-Ek specific and expressed Va15 rearranged to J01.1 orf1.3. The I-Ek-specific clones were
also homologous C'o each other and different from the I-A-reactive one in theD andN regions.
Four of the seven clones exhibited I-Ek-specific cytolytic activity. Each clone, when injected in
sublethal numbers into appropriate recipients, could induce resistance to a subsequent lethal dose
of any other clone in the panel . The resistance did not require sharing of either T cell receptor
/3 chains or antigen specificity, orMHC molecules by the eliciting and challenging clone . Cytolytic
and noncytolytic clones were equally efficient in inducing GVH resistance. A prerequisite of
resistance induction was the activation of eliciting clone subsequent to recognition of class II
molecules in the host . Clones preactivated with high concentrations of recombinant interleukin
2, in vitro, could induceGVH resistance also in syngeneic hosts, suggesting that resistance induction
was associated with the activated state of clone, rather than antigen recognition per se . In all
instances of resistance, the challenging clones failed to induce vascular leakage, which was the
cause of death in susceptible recipients (Lehmann, P. V., G . Schumm, D . Moon, U. Hurtenbach,
F. Falcioni, S. Muller, and Z . A . Nagy. 1990 .J. Exp . Med . 171:1485) . Lipopolysaccharide (LPS)
induced resistance to vascular leakage did not provide crossresistance to GVH and vice versa,
suggesting that interleukin lot and tumor necrosis factor ct implicated in LPS resistance are not
involved inGVH resistance. Although the mechanism remains unclear, the most likely explanation
for GVH resistance in this system is either the downregulation of permeability increasing effect
in the challenging clone, or an induced refractoriness of blood vessels to this effect .
Injection of limiting numbers oflymphoid cells from MHC-
homozygous donors into semisyngeneic or immunocom-
promised allogeneic recipients leads to resistance to a subse-
quent challenge with large numbers of lymphoid, cells that
would otherwise cause a graft-versus-host (GVH) reaction,
manifested in lymph node swelling or lethality (1, 2, and
reviewed in reference 3) . ThisGVH resistance is ofrapid onset
(detectable from day 3 to 10) and short duration (rarely de-
tectable after day 14) . Experimental systems using polyclonal
lymphoid cell populations for the induction of GVH resis-
tance have yielded results suggesting that the major mecha-
nism underlying GVH resistance is a T cell response of the
recipient directed against antigen receptors of the injected
T cells recognizing host alloantigens (2) . Such receptors are
forbidden in a healthy animal for reasons ofself-tolerance (4),
and thus, they may serve as immunogens in a GVH situa-
tion . Evidence favoring an antiidiotypic immune mechanism
for GVH resistance includes, first, that the resistance extends
only to T cells specific for the sameMHC molecules, second,
that it is not restricted by theMHC of the resistance-inducing
cells, and third, that it can be adoptively transferred to naive
recipients (2) . The nature ofthe effector cell mediatingGVH
resistance has remained unclear ; CTL or other types of sup-
pressive cells have been implicated (5-8) .
In the experiments reported here, we have tested whether
alloreactive T cell clones can induce GVH resistance, and,
ifso, by what mechanism . The data demonstrate that a short-
term GVH resistance, similar to the one induced by poly-
clonal lymphoid cells, can also be induced by class II-reactive
T cell clones . This resistance is dependent on the activation
of cloned T cells in the recipients, and it seems to result from
several different (including nonimmunological) mechanisms.
Materials and Methods
Mice. 8-wk-old specific pathogen-free mice of strains
B10.A(2R), B10.A(4R), B10.AQR, B10T(6R) (Olac Ltd ., Bicester,
UK) and BALB/c nu/nu (Iffa Credo, UArbresle, France) were used.
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TheT cell clones were isolated fromMLRcom-
binations B10T(6R) (K9,I-A9,I-E9,Dd) anti-B10.AQR (K9,IAk,
I-Ek,Dd), and B10.A(4R) (Kk,I-Ak,I-Eb,Db) anti-B10.A(2R) (Kk,
I-Ak,I-Ek,Db). Thus, the former combination can generate I-Ak-
as well as I-El-specific clones, whereas the latter can only generate
I-Ek-specific ones. Designation and properties of the clones are
summarized in Table 1 (see also reference 9) . The method of ex-
panding cloned cells to numbers required for in vivo experimenta-
tion have been described previously (9) .
In Vivo Assays with T Cell Clones.
￿
Activation of cloned T cells
in the recipients was measured by an in vivo ['H]thymidine in-
corporation assay as described previously (9). Briefly, 60 h after
injection of cloned cells, 0.5 MCi [3H]TdR was injected intrave-
nously, and 18 h later, thymidine incorporation was determined
in Soluene-dissolved organ samples. Under the conditions of this
assay, thebulk of injected thymidine is takenup by the cloned cells
themselves (9) . The additional host component ofuptake is depen-
dent on the antigen-specific activation of the cloned cells in vivo.
Homing of cloned cells was determined by injecting 5'Cr-labeled
cells intravenously, and the radioactivity of organs was measured
by gamma counting 24 h later (10). Vascular leakage induced by
T cell clones wasdetermined by extravasation of 12'1 human albu-
min (11) .
Determination of TCR-R Gene Segment Usage by T Cell Clones.
TotalRNA was prepared from 10' T cells as described (12) . 5-10
Pg of totalRNAwas used for the synthesis of first-strand cDNA
using reverse transcriptase (M-MuLV) and oligo p(dT)15 (Boehr-
inger, Mannheim, FRG) . The reaction was stopped by diluting
30-fold with water and heating to 95°C for 5 min . The cDNA
(1/100 to 1/300 of each sample)was amplifiedby PCR using one
of the VS primers together with theCS primer (Table 2) in each
reaction, at 1j.M final concentration. Amplification wasperformed
in 50 141 with 1.25U of Taq polymerase (Perkin Elmer, Kusnacht,
Switzerland), and a thermocycler (Cetus/Perkin Elmer) underthe
following conditions: 94°C melting for 20 s, 55°C annealing for
20 s, and 72°C extension for 30 sec . The amplified products were
separatedon a 1.6% agarose gel, and the respective V/O gene usage
was determined by the appearance of the relevant PCR fragment .
After identification oftheVO genes expressed, several identicalPCRs
were setup andpooled to obtain sufficient product for sequencing .
ThePCRfragment was purified either by anion exchange chroma-
tography (Quiagene tip 20; Diagene, Diisseldorf, FRG), or by
preparative agarose gel electrophoresis and isolation of theDNA
Table 1.
￿
Characteristics `of T Cell Clones Used in This Study
MLR of origin
Clone
￿
MHC molecule Cytolytic
designation R a S Exp. recognized activity'
4Ra
￿
4R ca 2R
￿
1
￿
I-Ek
￿
-
4Re
￿
4R a 2R
￿
1
￿
I-Ek
￿
-
4Rh
￿
4R a 2R 1
￿
I-Ek
￿
+
4R5
￿
4R a 2R 2
￿
I-Ek
￿
+
4R9
￿
4R a 2R 2
￿
I-Ek
￿
+
6Re
￿
6R a AQR 3
￿
I-Ek
￿
+
6R2
￿
6R a AQR 4
￿
I-Ak.d .e
Data are based on that in reference 9 .
Specific for the class 11 MHC molecule recognized.
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with Geneclean (Bio 101 ; La Jolla, CA). Purified DNA was se-
quenced directly using the dideoxy-chain termination method (13),
and the T7 polymerase as provided in the T7 sequencing TM kit
(Pharmacia Fine Chemicals, Dubendorf, Switzerland) . Theprimers
used for sequencing were the ones used for PCR (Table 2) .
Results
Demonstration ofGVH Resistance Induced by T Cell Clones.
As described previously, class 11-reactive T cell clones induced
lethal GVH reaction between day 3 and 5 after injection of
8 x 106 or more cells into recipients expressing the stim-
ulating MHC antigens (9) . Sublethal numbers (2-4 x 106)
of cloned cells caused no disease, or only transient symptoms
of disease developed, and the animals became resistant to a
subsequent injection of lethal numbers (up to 4 x 10') of
cloned cells . As shownin Table 3, eachTcell clonewascapable
of inducing resistance to itself. Theresistance wasmanifested
notonly in lack ofmortality, but also in the absence ofGVH
symptoms . The resistant animals survived for at least 1 yr.
The resistance developed 2-3 d after injection and lasted for
3-5 wk, depending on the clone administered (data not
shown) .
Elect ofIn Vivo Activation ofT Cell Clones onGVHResis-
tance . A critical step in the induction of lethal GVH was
activation of injected cells in the recipient (9). It was there-
fore conceivable that in the resistant animals activation might
have failed to occur upon secondary injection of the clone.
We tested this possibility by using an in vivo [ 3H]TdR in-
corporation assay, which reflects proliferation of the injected
clone as well as its capacity to induce increasedDNA syn-
thesis in the target organs (lungs and liver) . As shown in
Table 2. Primers Used for PCR and Sequencing
Specificity Sequence Reference
Vol AGCGCTGAGAAGCCGCCAGA 42
V/32 TCAAGCTGTGAACCTACGCT 42
V(33 GATGAGGTGTATCCCTGAAA 43
V/34 TTCATGTTTTCCTACAGCTA 44
V/05 ATTCTGGGGTTGTCCAGTCT 45
V06 CATGGTGATGGTGGCATCAT 44
V07 CCTGGTCTGGGGCTACAGCT 46
V08 AACACATGGAGGCTGCAGTC 45
V/39 TGATAAGATTTTGAACAGGG 44
Vo10 ACGAAACAGTTCCAAGGCGC 44
Vo11 CAAGCTCCTATAGATGATTC 44
V012 TTCCCCCTTATGGAAGATGG 44
V013 CCTAAAGGAACTAACTCCAC 44
V014 CCAGGTAGAGTCGGTGGTGC 47
V015 . ACTGTGAACTCAGCAATCAA 47
V016 AATGGTAAAGTCATGGAGAA 47
C(3 GATGGCTCAAACAAGGAGAC 48Table 3.
￿
Demonstration ofGVH Resistance. Each Clone
Induces Resistance to Itself
Fig . 1, the noncytolytic clones 6R2 and 4Ra induced com-
parable thymidine incorporation in susceptible and resistant
mice. In contrast, the cytolytic clones 6Re, 4R9, and 4R5
failed to incorporate, or incorporated significantly less thymi-
Figure 1 .
￿
Proliferation ofT cell clones in vivo in GVH-resistant mice .
The development ofGVH resistance elicited by 3 x 106 cells on day 1
was tested by a lethal dose (10') ofT cells on day 7 . In vivo proliferation
was determined 3d after a third injection ofT cells on day 14 . 18hbefore
the termination of experiment, 0.5 MCi [3H]TdRwas injected intrave-
nously, and thymidine incorporation in lungs and liver wasmeasured as
described (9). Each column represents themean (and SD) for three mice.
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dine in GVH-resistant animals, although they exhibited a
substantial primary thymidine incorporation . The failure of
cytolyticclones to proliferate in resistant animals was not due
to alteredhoming, since these clones, as exemplified by clone
6Re in Fig . 2, homed to lungs and liver in both susceptible
and resistant mice. One possible interpretation for the lack
of activation is that these clones have lysed the class 11-ex-
pressing stimulator cells in the target organs after the first
injection. Thus, the failure of secondary activation due to
antigen depletion in the host may be a possible mechanism
involved in GVH resistance, but it is certainly not an exclu-
sive one, since noncytolytic clones have been found to be-
come activated in resistant recipients .
GVH Resistance Is Neither MHC Restricted nor TCR-/3
Speck. We investigated whether or not GVH resistance
resulted from an immune response of the host against the
priming clone. As shown in Table 4, clones ofB10T(6R)
and B10.A(4R) origin inducedresistance against each other.
Since these two strains differ at all class I and II MHC loci,
the resistance is obviously not restricted by theMHC of the
Table 4.
￿
Induction of Crossresistance
ofMHC Restriction
and Absence
Figure 2 .
￿
Homing of T cell clone
We inGVH-resistant mice . Percent ac-
tivity relates to the total radioactivity
recovered from all organs (correspond-
ing to 70-80% of injected radioac-
tivity). Each column represents the
mean (and SD) for three mice. (#) Cr-
labelled cells injected .
T cell clone
Day 1
injected
Day 7
Recipient
strain
Mortality
by day 13
6R2 (3 x 106) 4R9 (10') B10.AQR 1/7
- 4R9 (10') B10.AQR 3/3
6R2 (3 x 106) 4R5 (10') B10.AQR 013
- 4R5 (10') B10.AQR 3/3
4Re (10') 6R2 (10') B10.A(2R) 0/3
- 6R2 (10') B10.A(2R) 3/3
4Re (10) 4R9 (10') B10.A(2R) 113
- 4R9 (10') B10.A(2R) 3/3
4R9 (2 x 106) 6Re (10') B10.A(2R) 0/3
- 6Re (10') B10.A(2R) 3/3
4Rh (3 x 106) 6R2 (10') B10.A(2R) 0/3
- 6R2 (10') B10.A(2R) 3/3
6Re (3 x 106) 6R2 (10') B10.AQR 0/8
- 6R2 (10') B10.AQR 3/3
T cell clone
Day 1
injected
Day 7
Recipient
strain
Mortality
by day 13
6R2 (3 x 106) 6R2 (10') B10.AQR 0/4
6R2 (10') B10.AQR 3/3
6Re (3 x 106) 6Re (10') B10.AQR 0/5
- 6Re (10') B10.AQR 4/4
4R9 (2 x 106) 4R9 (8 x 106) B10.A(2R) 0/3
- 4R9 (8 x 10 6) B10.A(2R) 3/3
4Rh (4 x 106) 4Rh (10') B10.A(2R) 1/4
- 4Rh (10') B10.A(2R) 4/4
4R5 (3 x 106) 4R5 (10') B10.A(2R) 0/3
- 4R5 (10') B10.A(2R) 3/3p
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U U U U Upriming clone. Moreover, the I-Ak-specific clone 6R2 in-
duced resistance against several I-Ek-specific clones and vice
versa. The latter result indicates that sharing of antigen
specificity by clones is not required for the induction ofGVH
resistance in this system . To further investigate whether an
immune response against the antigen receptor of the clones
may be involved in GVH resistance, we have characterized
the /3 chain of TCR expressed by these clones. The results
in Table 5 demonstrate that the I-Ak-specific clone 6R2 ex-
presses V08.3 and J01 . 5 . In contrast, all I-Ek-specific clones
useV015 . Five out ofthese six clones use Jo1 .1, and exhibit
identical amino acid sequence in the N andD regions . At
least four of the latter five clones are distinct, as judged by
the strain of origin (4R or 6R), the experiment of origin
(see in Table 1), and a difference in the N region nucleotide
sequence (clone 4R5) . The remaining I-Ek-specific clone
4Re uses JO1 .3 and differs from the others in theN region .
Thus, the I-Ek-specific clones exhibit a striking homology
in terms ofTCR-R usage, although they derive from three
different groups of mice belonging to two different (fully
MHC-disparate) strains . These data indicate that an immune
response against TCR a chains could explain the cross-
resistance between I-Ek-specific clones, but not the cross-
resistance between the I-Ek- and I-Ak-reactive ones . The
possible role of an anti-TCR a chain immunity remains to
be investigated .
InductionofGVHResistance in MHC-disparate Recipients and
in Athymic Nude Mice . We have investigated whether im-
munization of recipients with MHC-disparate cells would
induce a protective host response against a pathogenic clone
sharing MHC with the priming cells . To this end, the I-Ek-
specific clone6Re was injected into MHC-disparate B10.A(4R)
or B10.M (H-2f) recipients, which do not express the
stimulating class 11 molecule, and thus, the clone does not
recognize any host antigens. 7 d later, the I-Ak- and I-Af-
specific clone 6R2 was injected in a lethal dose (Table 6) .
Table 6.
￿
MHC Disparity Between Priming Clone and Recipient
Does Not Induce Immunity to Protect from Lethal GVH
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Although the priming and challenging clones were MHC
identical, 6Re failed to induce resistance to 6R2 . The failure
of resistance induction was not due to altered homing (data
not shown) . In the same experiment, We did induce resis-
tance to 6R2 in B10.AQR mice expressing I-Ek to which
We was specific . Similarly, clone 6R2 induced resistance
against itself in B10.M and B10.A(4R) recipients . Thus,
antigen-specific activation of the priming clone in the recip-
ient seems to be critical for the induction ofGVH resistance,
whereas a possible host response against strong alloantigens
expressed by the clone (e.g., MHC) does not protect from
lethal GVH reaction. We then investigated whether the host's
T cell compartment was required for the development ofGVH
resistance . As demonstrated in Table 7, the I-Ad-reactive
clone 6R2 could readily induce GVH resistance in young
athymic BALB/c nu/nu mice, whose T cell system is severely
deficient . Taken together, it appears that immune responses
of the host do not play a major role in the development of
T cell clone-induced GVH resistance.
Activation of the Priming T Cell Clone Is Required for the
Induction ofGVH Resistance. The data so far have indicated
that the priming clone must recognize host antigens for the
development ofGVH resistance. To dissect whether antigen
recognition itself or the subsequent T cell activation is rele-
Table 8.
￿
GVH Resistance Is Induced in Syngeneic Recipients
by T Cell Clones Preactivated In Vitro
Clone injected on :
T cell clone
Day 1
injected
Day 7
Recipient
strain
Mortality
by day 13
Recipient Mortality
Preactivation' Day 1 Day 3 strain by day 8
rIL-2 4R9 (10') 6R2 (10 1) 4R 0/3
- 6R2 (107) B10.M 3/3 - 4R9 (10') 6R2 (10') 4R 3/3
6Re, 3 x 106 6R2 (10') B10.M 4/4
6R2, 3 x 106 6R2 (10 7) B10.M 0/3 HL-2 4Rh (10') 6R2 (10 1) 4R 0/3
- 6R2 (10') B10.AQR 3/3 - 4Rh (10') 6R2 (10 1) 4R 3/3
We, 3 x 106 6R2 (10') B10.AQR 0/3 rIL-2 4R5 (10') 6R2 (10') 4R 0/3
- 6R2 (10') B10.A(4R) 3/3
- 4R5 (10') 6R2 (107) 4R 3/3
- We (10') B10.A(4R) 0/4
6Re, 3 x 10 6 6R2 (10') B10.A(4R) 3/3 " 1 wk after the last restimulation with 10 ng/ml rIL-2, the eliciting
We, 10' 6R2 (10') B10.A(4R) 3/3 clone was cultured with 100 ng/ml HL-2 for 12 h, washed, and injected
6R2, 3 x 106 6R2 (10') B10.A(4R) 0/4
into appropriate recipients . In the control group, the cells were left in
the standard culture medium (with 10 ng/ml rIL-2, changed 7 d before)
for the last 12 h of culture, washed, and injected as above .
Table 7 .
T cell
GVH Resistance in
clone injected
Nude Mice
Recipient Mortality
Day 1 Day 7 strain by day 13
6R2 (10') - BALB/c nu/nu 0/4
6R2 (10') 6R2 (2 x 10') BALB/c nu/nu 0/8
- 6R2 (2 x 10') BALB/c nu/nu 6/6vant to GVH resistance, we have attempted to induce resis-
tance in syngeneic recipients with clones in different states
of activation . As shown in Table 8, cloned cells preactivated
with high concentrations rIL2 in vitro readily induced resis-
tance in syngeneic mice, whereas resting cells failed to do
so. Thus, resistance appears to be a consequence ofT cell
activation thatmay or may not occur via the antigen receptor.
LPS Resistance andGVH Resistance Are Mediated by Different
Mechanisms. T cell clone-induced acute GVH, as well as
LPS-induced lethal disease, are manifested in shock . The two
conditions are also similar in that a first sublethal encounter
induces resistance against a second lethal one. We therefore
investigated whether LPS-induced resistance to shock would
protect the animals also from lethal GVH . As shown in Table
9, pretreatment of LPS-sensitive C3H/HeN mice with 25
ug LPS induced resistance to a lethal dose (400 ug) ofLPS.
The same treatment, however, failed to provide protection
against a lethal dose of clone 6R2 . Conversely, GVH resis-
tance induced by T cell clones failed to protect the animals
against a lethal dose ofLPS. It has been described that ILla
338 Graft-vs.-Host Resistance Induced by T Cell Clones
and TNF-a are involved in the induction ofLPS resistance
(14). Thus, the absence ofLPS-GVH crossresistance indicates
that GVH resistance is independent of Ilrlot and TNF-a-
related mechanisms.
Absence of Vascular Leakage in GVH-resistant Animals.
￿
We
have shown previously that vascular leakage is a major
symptom and probably also the cause of death in T cell
clone-induced acute GVH reaction (9). We therefore asked
whether thecloneswere also capableofcausing vascular leakage
in GVH-resistant animals. As shown in Fig. 3, the extravasa-
tion of 1251 albumine was not increased above the controls
in animals resistant to clone 6R2 . The same clone induced
significant vascular leakage in nonresistant animals. GVH re-
sistance paralleled the absence of vascular leakage in both eu-
thymic and athymic mice (Fig . 3) . The clone used in this
experiment had been shown before to become activated after
secondary injection in the host (see in Fig. 1), and yet, it
failed to induce vascular leak syndrome . Thus, the absence
of vascular leakage in GVH resistance is due to either an al-
tered eflector function of the inducingT cellsupon secondary
Figure 3.
￿
Extravasation of 1251-albumine in
GVH-resistant mice. Extravasation was mea-
sured2h after intravenous injection of0.5 ttCi
1251 human albumine as described (11) . Each
column represents themean (and SD) for four
mice .
Table 9 . LPS Resistance Does Not Protect from Lethal GVH Induced by T Cell Clones
Treatments
Recipient
strain Day 1 Day 9 Day 15 Mortality
C3H/HeJ LPS (400 Pg) 0/3
C3H/HeN LPS (400 tog) 4/4
C3H/HeN LPS (100 Ag) 0/4
C3H/HeN LPS (25 gg) LPS (400 F1g) 0/4
C3H/HeN LPS (25 ktg) 6R2 (10) 3/3
C3H/HeN LPS (25 fsg) LPS (400 Fig) 6R2 (1 4/4
C3H/HeN - 4R9 (106) 6R2 (107) 0/3
C3H/HeN - 6R2 (107) 3/3
C3H/HeN 4R9 (106) 6R2 (101) LPS (400 ug) 2/3injection, or a decreased sensitivity of capillary walls to the
permeability-inducing effect.
Discussion
Resistance to local as well as systemic GVH reaction can
be induced by injecting a small dose ofparental lymphocytes
into Ft hybrid recipients (1, 2, 3, 7). Similarly, in animal
models of autoimmunity, a resistance to disease develops
after nonpathogenic administration ofthe autoantigen or the
disease-inducing cells (15-21), or after recovery from a dis-
ease episode (21-24). Resistance to these disease conditions
appears to be mediated by T cells (usually of the suppressor/
cytotoxic type) that recognize the antigen receptors of the
disease-inducing (usually helper type) T cells (6-8, 25, 26).
However, this resistance mechanism is not found in certain
GVH systems (8, 27) . In addition to specific antireceptor im-
munity, several other host-derived mechanisms may contribute
to the development of resistant state, including T cell-medi-
ated undefined nonspecific mechanisms (27), suppression by
antiergotypic T cells directed against markers on activated
T cells (28), suppression mediated by "inappropriate" APC
(29), and decreased skin reactivity due to the action of
Thy-1+ epidermal cells (30).
We have demonstrated previously that alloreactive, class
II MHC-specific T cell clones can induce a lethal GVH reac-
tion, when injected into recipients of the stimulator strain
(9). In this communication, we have shown that the same
T cell clones injected in sublethal doses render the host resis-
tant to a subsequentlethal dose of the cloned cells. The resis-
tance was demonstrable from day 3 after injection and lasted
for ti1 mo. To investigate whether the clone-induced resis-
tance exhibits immunological specificity, we have used different
T cell clones for elicitation and challenge. Since the GVH
resistance induced by bulk lymphoid cells has been consid-
ered to result from a specific immune response against TCRs
expressed by the pathogenic T cells, the use of clones with
different TCRs should allow us to address the question of
specificity at the clonal level. The panel ofT cell clones used
in these experiments included six I-Ek-specific and one IAk-
specific clone. Surprisingly, all I-Ek-specific clones expressed
V015 with minimal variations in terms ofJa usage and N
region sequence, although they derived from different mice
of two fully MHC-disparate strains. It remains to be inves-
tigated whether or not this observation represents another
example of restricted TCR-(3 usage among I-E-reactive cells
(31-33). In any case, this finding suggests that the cross-
resistance between different I-Ek-specific. clones could, in
principle, be due to an immune response against TCR (3
chain-associated determinants. However, this explanation
cannot apply to the observed crossresistance between I-Ek-
and I-Ak-specific clones, since the latter expresses a com-
pletely different TCR-(3 (VO8.3, J,Q1.5, and a different N
region sequence). The data leave open the possibility of an
immune response to TCR a chain-associated determinants
in the latter case of crossresistance. Alternatively, antiTCR
immunity may not be involved here.
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Since the clone-induced GVH resistance failed to exhibit
any known immunological specificity, we have sought for
alternative criteria that may be relevant for induction of the
resistant state. We have found that activation of the eliciting
clone in the host is a prerequisite ofresistanceinduction. This
occurs normally upon specific recognition ofhost classII mol-
ecules by the clone, but the recognition phase can be artificially
circumvented by preactivating the clone with high concen-
trations of IL -2 in vitro. Such preactivated cells can induce
GVH resistance in syngeneic recipients. The latter finding
indicates that it is not antigen recognition per se, but the
subsequent activation of T cells, which is relevant to resis-
tance induction. We then asked whether the activated state
of the T cell clone induces a so far undetected (i.e., not an-
tireceptor) type of immune response. Several lines of evidence
indicate that this may not be the case: first, GHV resistance
lacks MHC restriction; second, it can be induced in athymic
nude mice; and third, it cannotbe transferred to naive recipients
by either lymphoid cells or serum (P.V Lehmann, unpub-
lished observation) . The latter finding is in contrast to the
reported transfer of GVH resistance induced by bulk cell popu-
lations (2). This discrepancy may be explained by the different
homing patterns ofbulk lymphoid cells and clones: the former
seed in lymphoid tissues (34), whereas the latter home al-
most exclusively to lungs and liver (35, 36) .
Since immune responses of the host do not seem to be
critical for GVH resistance in our system, it is reasonable to
assume that resistance is induced directly by the injected clone.
One possible mechanism revealed by this study is that cyto-
lytic clones may induce GVH resistance by killing the class
II-positive cells in the target organs, and thereby preventing
the activation ofthe challenging clone. However, the finding
that noncytolytic clones also generate resistance implies that
depletion of stimulator cells may not be a major mechanism.
One striking finding was the absence of vascular leakage in
GVH resistance. Since the cause oflethality in clone-induced
GVH was a circulation disturbance (9), the absence of vas-
cular leakage alone can explain the resistance. Although acti-
vated T cells are known to increase vascular permeability (37,
38), the mechanism by which they perform this function is
unclear. Perhaps an antigen-induced endoglycosidase (39, 40)
or a lymphokine(s) is involved. In the latter case, the lym-
phokine is not likely to be either ILla or TNF-a, since LPS
resistance, where these two lymphokines are involved, does
not provide crossresistance to lethal GVH reaction. It is pos-
sible that the permeability-increasing effect is associated with
a so far unknown T cell lymphokine. GVH resistance could
then be the consequence of altered lymphokine production
upon secondary injection. Downregulation of some effector
functions of the challenging clone by the eliciting clone (41)
couldbring about this alteration. Another possibility is that
a refractoriness of capillary walls develops to the permeability-
increasing effect. Further investigations aimed at clarifying
the mechanisms whereby T cells influence blood vessels could
be of clinical importance in overcoming the side effects of
lymphokine therapy and in preventing shock.References
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